Simple lab notes could save lives: 125,000-Patient trial launches

NCT ID NCT07634718

Not yet recruiting Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether adding health messages to lab reports can reduce serious heart and kidney problems in people with both diabetes and chronic kidney disease. Over 125,000 participants will be randomly assigned to receive either routine care or extra health messages in their lab results, plus an educational video. The goal is to see if this low-cost approach can improve outcomes like heart attacks, strokes, and kidney failure.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If it works, this could show that simple health messages in lab reports help prevent serious heart and kidney problems in people with diabetes and kidney failure.
What could go wrong: This is a large but early-stage implementation study, not a drug trial. The messages may have little effect on real-world outcomes, and results may not apply outside France.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic renal failure syndrome diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES RENAL FAILURE , CHRONIC

Contacts and locations

Locations

Biogroup laboratories

Nantes, 44000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.